34 results
Pathogenesis of Nonalcoholic Steatohepatitis. Various factors, including inflammation, hyperinsulinemia or insulin resistance, and altered lipid homeostasis,
Pathogenesis of Nonalcoholic ... Pathophysiology #GI ... NonAlcoholicSteatoHepatitis #NonAlcoholicFattyLiverDisease
Histologic Features and Prevalence of Nonalcoholic Steatohepatitis (NASH). NASH is a potentially progressive type of nonalcoholic
Prevalence of Nonalcoholic ... progressive type of nonalcoholic ... NonAlcoholicSteatoHepatitis #NonAlcoholicFattyLiverDisease
Common Etiologies of Cirrhosis

Inflammation

 - Hepatitis B (15 percent)

 - Hepatitis C (47 percent)

 - Schistosomiasis
Hemochromatosis - Nonalcoholic ... #Differential #Hepatology
A summary of GI Lymphomas - Primary Lymphoid Neoplasms of the GI Tract
T-Cell
 - EATL
 -
A summary of GI ... Neoplasms of the GI ... Lymphomas #GITract #hematology
Idiopathic Thrombocytopenic Purpura 
Clinical:
 • Gingival 
 • Menorrhagia 
 • GI bleeding 
 • Intracranial
Menorrhagia • GI ... Diagnosis #Overview #Hematology
Von Willebrand Disease - Most common inherited bleeding disorder 
Clinical 
 • Easy bruising 
 •
oropharyngeal, GI ... Disease #Diagnosis #Hematology
Diagnosis and management of Polyarteritis Nodosa (PAN)

Chapel Hill 2012 definition: 
Necrotizing vasculitis ofmedium or small arteries
140 umol/L - GI ... PolyarteritisNodosa #Rheumatology
Stevens Johnson Syndrome and Toxic Epidermal Necrolysis - Causative Medications 
and Level of Suspicion 

High Risk:
Antigout:
sulfadiazine, sulfadoxine GI ... Epidermal #Necrolysis #Dermatology
Tranexamic Acid - Indications and Pharmacology
Pharmacokinetics:
 • MOA: Inhibits plasminogen activation to plasmin & inhibits fibrinolysis
TBI, Hemoptysis, GI ... #Pharmacology #hematology
Non-alcoholic fatty liver disease algorithm.
 
For those patients with NAFLD or liver disease of unknown aetiology,
#NonAlcoholic #FattyLiver ... Referral #Management #Hepatology